06.10.2020 • NewsK+S

K+S in Americas Sale Talks with Stone Canyon

Responding to market rumors, German potash and salt company K+S has confirmed it is in “very advanced negotiations” with US-based global industrial holding company Stone Canyon Industries Holdings about a potential sale of its Americas operating unit.

The Kassel-headquartered group stated that it expects the price to be $3.2 billion but added that agreements have not been signed and there is no certainty that a deal can be reached.

Having decided on the divestment in a move to generate value and reduce debt, K+S mandated banks in March to sell the business, which includes salt operations in North and South America, as well as Morton Salt and K+S Chile. The company’s new 2 million t/y potash mine in Bethune, Saskatchewan, Canada, is not part of the sale.

Stone Canyon already operates a salt business. It created SCI Salt, following the $2 billion acquisition on Apr. 1 of Kissner, a US producer of bulk, specialty and evaporated salt. Kissner’s operations comprise two rock salt mines in Detroit, Michigan, and Lyons, Kansas; an evaporated salt business, including a refinery in Watkins Glen, New York; three salt production facilities co-located on potash mines in Western Canada; multiple packaging facilities and a network of distribution and storage facilities throughout the US.

 

Author: Elaine Burridge, Freelance Journalist

German potash company K+S has confirmed it is in “very advanced...
German potash company K+S has confirmed it is in “very advanced negotiations” with US-based global industrial holding company Stone Canyon Industries Holdings about a potential sale of its Americas operating unit. The price is expected to be $3.2 billion. (c) K+S Aktiengesellschaft

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.